In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2026-01-01
DOI
https://doi.org/10.7326/annals-25-04963-jc
Primary Topic
Blood Coagulation and Thrombosis Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo

Andrew Dunn
Annals of Internal Medicine
Blood Coagulation and Thrombosis Mechanisms
article

In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo

Andrew Dunn
article en

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 179(1)
Mount Sinai Health System (US)
Openalex Percentile: Top 95%
Blood Coagulation and Thrombosis Mechanisms
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo — Andrew Dunn · Annals of Internal Medicine (2026) | TGRS Research Map | TGRS